Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)

Abstract Digital medicine is an interdisciplinary field, drawing together stakeholders with expertize in engineering, manufacturing, clinical science, data science, biostatistics, regulatory science, ethics, patient advocacy, and healthcare policy, to name a few. Although this diversity is undoubted...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jennifer C. Goldsack, Andrea Coravos, Jessie P. Bakker, Brinnae Bent, Ariel V. Dowling, Cheryl Fitzer-Attas, Alan Godfrey, Job G. Godino, Ninad Gujar, Elena Izmailova, Christine Manta, Barry Peterson, Benjamin Vandendriessche, William A. Wood, Ke Will Wang, Jessilyn Dunn
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Acceso en línea:https://doaj.org/article/1b5f94c494b5431a8b26ec28113f48ab
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1b5f94c494b5431a8b26ec28113f48ab
record_format dspace
spelling oai:doaj.org-article:1b5f94c494b5431a8b26ec28113f48ab2021-12-02T15:51:17ZVerification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)10.1038/s41746-020-0260-42398-6352https://doaj.org/article/1b5f94c494b5431a8b26ec28113f48ab2020-04-01T00:00:00Zhttps://doi.org/10.1038/s41746-020-0260-4https://doaj.org/toc/2398-6352Abstract Digital medicine is an interdisciplinary field, drawing together stakeholders with expertize in engineering, manufacturing, clinical science, data science, biostatistics, regulatory science, ethics, patient advocacy, and healthcare policy, to name a few. Although this diversity is undoubtedly valuable, it can lead to confusion regarding terminology and best practices. There are many instances, as we detail in this paper, where a single term is used by different groups to mean different things, as well as cases where multiple terms are used to describe essentially the same concept. Our intent is to clarify core terminology and best practices for the evaluation of Biometric Monitoring Technologies (BioMeTs), without unnecessarily introducing new terms. We focus on the evaluation of BioMeTs as fit-for-purpose for use in clinical trials. However, our intent is for this framework to be instructional to all users of digital measurement tools, regardless of setting or intended use. We propose and describe a three-component framework intended to provide a foundational evaluation framework for BioMeTs. This framework includes (1) verification, (2) analytical validation, and (3) clinical validation. We aim for this common vocabulary to enable more effective communication and collaboration, generate a common and meaningful evidence base for BioMeTs, and improve the accessibility of the digital medicine field.Jennifer C. GoldsackAndrea CoravosJessie P. BakkerBrinnae BentAriel V. DowlingCheryl Fitzer-AttasAlan GodfreyJob G. GodinoNinad GujarElena IzmailovaChristine MantaBarry PetersonBenjamin VandendriesscheWilliam A. WoodKe Will WangJessilyn DunnNature PortfolioarticleComputer applications to medicine. Medical informaticsR858-859.7ENnpj Digital Medicine, Vol 3, Iss 1, Pp 1-15 (2020)
institution DOAJ
collection DOAJ
language EN
topic Computer applications to medicine. Medical informatics
R858-859.7
spellingShingle Computer applications to medicine. Medical informatics
R858-859.7
Jennifer C. Goldsack
Andrea Coravos
Jessie P. Bakker
Brinnae Bent
Ariel V. Dowling
Cheryl Fitzer-Attas
Alan Godfrey
Job G. Godino
Ninad Gujar
Elena Izmailova
Christine Manta
Barry Peterson
Benjamin Vandendriessche
William A. Wood
Ke Will Wang
Jessilyn Dunn
Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)
description Abstract Digital medicine is an interdisciplinary field, drawing together stakeholders with expertize in engineering, manufacturing, clinical science, data science, biostatistics, regulatory science, ethics, patient advocacy, and healthcare policy, to name a few. Although this diversity is undoubtedly valuable, it can lead to confusion regarding terminology and best practices. There are many instances, as we detail in this paper, where a single term is used by different groups to mean different things, as well as cases where multiple terms are used to describe essentially the same concept. Our intent is to clarify core terminology and best practices for the evaluation of Biometric Monitoring Technologies (BioMeTs), without unnecessarily introducing new terms. We focus on the evaluation of BioMeTs as fit-for-purpose for use in clinical trials. However, our intent is for this framework to be instructional to all users of digital measurement tools, regardless of setting or intended use. We propose and describe a three-component framework intended to provide a foundational evaluation framework for BioMeTs. This framework includes (1) verification, (2) analytical validation, and (3) clinical validation. We aim for this common vocabulary to enable more effective communication and collaboration, generate a common and meaningful evidence base for BioMeTs, and improve the accessibility of the digital medicine field.
format article
author Jennifer C. Goldsack
Andrea Coravos
Jessie P. Bakker
Brinnae Bent
Ariel V. Dowling
Cheryl Fitzer-Attas
Alan Godfrey
Job G. Godino
Ninad Gujar
Elena Izmailova
Christine Manta
Barry Peterson
Benjamin Vandendriessche
William A. Wood
Ke Will Wang
Jessilyn Dunn
author_facet Jennifer C. Goldsack
Andrea Coravos
Jessie P. Bakker
Brinnae Bent
Ariel V. Dowling
Cheryl Fitzer-Attas
Alan Godfrey
Job G. Godino
Ninad Gujar
Elena Izmailova
Christine Manta
Barry Peterson
Benjamin Vandendriessche
William A. Wood
Ke Will Wang
Jessilyn Dunn
author_sort Jennifer C. Goldsack
title Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)
title_short Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)
title_full Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)
title_fullStr Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)
title_full_unstemmed Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)
title_sort verification, analytical validation, and clinical validation (v3): the foundation of determining fit-for-purpose for biometric monitoring technologies (biomets)
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/1b5f94c494b5431a8b26ec28113f48ab
work_keys_str_mv AT jennifercgoldsack verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT andreacoravos verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT jessiepbakker verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT brinnaebent verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT arielvdowling verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT cherylfitzerattas verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT alangodfrey verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT jobggodino verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT ninadgujar verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT elenaizmailova verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT christinemanta verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT barrypeterson verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT benjaminvandendriessche verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT williamawood verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT kewillwang verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
AT jessilyndunn verificationanalyticalvalidationandclinicalvalidationv3thefoundationofdeterminingfitforpurposeforbiometricmonitoringtechnologiesbiomets
_version_ 1718385557731540992